145 related articles for article (PubMed ID: 33137430)
1. Effects of rhein and Rheum palmatum L. extract on the pharmacokinetics and tissue distribution of aristolochic acid I and its demethylated metabolite in rats.
Ma L; Shen Z; Hu H; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2021 Mar; 267():113537. PubMed ID: 33137430
[TBL] [Abstract][Full Text] [Related]
2. Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats.
Ma L; Zhao L; Hu H; Qin Y; Bian Y; Jiang H; Zhou H; Yu L; Zeng S
J Ethnopharmacol; 2014 May; 153(3):864-71. PubMed ID: 24685584
[TBL] [Abstract][Full Text] [Related]
3. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
[TBL] [Abstract][Full Text] [Related]
4. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
Stiborova M; Frei E; Arlt VM; Schmeiser HH
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
[TBL] [Abstract][Full Text] [Related]
5. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
[TBL] [Abstract][Full Text] [Related]
6. Enzymes metabolizing aristolochic acid and their contribution to the development of aristolochic acid nephropathy and urothelial cancer.
Stiborová M; Martínek V; Frei E; Arlt VM; Schmeiser HH
Curr Drug Metab; 2013 Jul; 14(6):695-705. PubMed ID: 23701164
[TBL] [Abstract][Full Text] [Related]
7. Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy.
Li C; Wang X; Bi Y; Yu H; Wei J; Zhang Y; Han L; Zhang Y
Toxicol Sci; 2020 Jun; 175(2):279-291. PubMed ID: 32159797
[TBL] [Abstract][Full Text] [Related]
8. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
[TBL] [Abstract][Full Text] [Related]
9. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
Wang L; Pan X; Sweet DH
Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
[TBL] [Abstract][Full Text] [Related]
10. Role of cytochromes P450 1A1/2 in detoxication and activation of carcinogenic aristolochic acid I: studies with the hepatic NADPH:cytochrome P450 reductase null (HRN) mouse model.
Levová K; Moserová M; Kotrbová V; Sulc M; Henderson CJ; Wolf CR; Phillips DH; Frei E; Schmeiser HH; Mares J; Arlt VM; Stiborová M
Toxicol Sci; 2011 May; 121(1):43-56. PubMed ID: 21362632
[TBL] [Abstract][Full Text] [Related]
11. Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters.
Yuan Y; Yang H; Kong L; Li Y; Li P; Zhang H; Ruan J
Chem Biol Interact; 2017 Nov; 277():79-84. PubMed ID: 28890383
[TBL] [Abstract][Full Text] [Related]
12. Organic anion transporter 1 (OAT1) involved in renal cell transport of aristolochic acid I.
Zeng Y; Zhang R; Wu J; Liu M; Peng W; Yu X; Yang X
Hum Exp Toxicol; 2012 Aug; 31(8):759-70. PubMed ID: 22027505
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of rhubarb anthraquinones extract in normal and disease rats.
Li P; Lu Q; Jiang W; Pei X; Sun Y; Hao H; Hao K
Biomed Pharmacother; 2017 Jul; 91():425-435. PubMed ID: 28475921
[TBL] [Abstract][Full Text] [Related]
14. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
[TBL] [Abstract][Full Text] [Related]
15. The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats.
Stiborová M; Levová K; Bárta F; Šulc M; Frei E; Arlt VM; Schmeiser HH
Mutagenesis; 2014 May; 29(3):189-200. PubMed ID: 24598128
[TBL] [Abstract][Full Text] [Related]
16. Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid.
Stiborová M; Frei E; Arlt VM; Schmeiser HH
Xenobiotica; 2014 Jan; 44(2):135-45. PubMed ID: 24152141
[TBL] [Abstract][Full Text] [Related]
17. A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches.
Stiborová M; Bárta F; Levová K; Hodek P; Schmeiser HH; Arlt VM; Martínek V
Int J Mol Sci; 2015 Nov; 16(11):27561-75. PubMed ID: 26593908
[TBL] [Abstract][Full Text] [Related]
18. Steady-state pharmacokinetics and tissue distribution of anthraquinones of Rhei Rhizoma in rats.
Shia CS; Tsai SY; Lin JC; Li ML; Ko MH; Chao PD; Huang YC; Hou YC
J Ethnopharmacol; 2011 Oct; 137(3):1388-94. PubMed ID: 21855620
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2.
Liao XY; Deng QQ; Han L; Wu ZT; Peng ZL; Xie Y; Wang GJ; Aa JY; Pan GY
Acta Pharmacol Sin; 2020 Jan; 41(1):129-137. PubMed ID: 31341258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
